NUA SURGICAL

We are delighted to welcome Anna Nestor to the NUA leadership team as VP of Quality. Anna brings over two decades of experience to the role, having held senior leadership positions with major life science companies including Teleflex, Organon, Viatris, Covidien and Merck Sharpe & Dohme. In addition to this, Anna has been instrumental in introducing innovative devices into women’s health, having managed the effective transfer of the Jada System for postpartum haemorrhage from Alydia Health into Organon following the acquisition. Anna is a Galway native and studied at both the Atlantic Technological University and the University of Galway, holds degrees in engineering and commerce and a masters degree in technology management. Although she has worked across many geographies over the past twenty years, finding a suitable role in a Galway-based start-up was an opportunity that Anna wanted to explore. Speaking about the announcement, our CEO Barry Mc Cann stated “I have known Anna for a number of years and I have no doubt that she is a brilliant fit for our company. Anna further strengthens our leadership team and it is a major boost for us to secure her expertise as we develop our quality systems for the SteriCISION device.”   Padraig Maher, Marie-Therese Maher, Anne Geary Schmults, Elizabeth Garner, Robert Bilkovski, MD, MBA

Merry Christmas to our friends, colleagues, collaborators and investors. At this time of year, we particularly send our warm wishes and appreciation to all maternal health staff around the world that are delivering the next generation throughout the holiday season. #childbirth #maternal #health

Our Board Chair Dr Elizabeth Garner provides an excellent summary of some of the amazing work being done in women's health research, as presented recently at the White House. With more funding, so much more can be achieved!

Last week, the President and the First Lady hosted the “White House Conference on Women’s Health Research,” organized by The White House (WH) Initiative on Women’s Health Research and the Milken Institute Health. What a brilliant way to end 2024 and to look forward toward the continued elevation of women’s health! I listened to the recording over the weekend because I realized that there were so many words of wisdom and deep insights shared by the speakers, and I wanted to capture them all! Over the next few days, I'll be posting some of the key takeaways I gathered from the meeting. The morning began with comments from Jennifer Klein (WH Gender Policy Council), Carolyn M. Mazure (WH Initiative on Women’s Health Research), Maria Shriver (Women’s Alzheimer’s Movement), and Esther Krofah (Milken Institute Health). 🔸 Jennifer Klein noted the nearly $1 billion already committed for women's health research. Agencies have strengthened their research and data standards to ensure that women are considered at every point in the research process. 🔸 Dr. Mazure emphasized that women's health is now a recognized field of scientific study, and that the stage has been set to grow its scope and depth. 🔸 Esther Krofah highlighted Milken's work designing funding and partnership solutions to bridge gaps and spur innovation. I found Maria Shriver's remarks particularly powerful and moving: some quotes: 💠 "...this issue is one of health equity and justice for women.” 💠 “Without our health, we cannot work, we cannot parent, and we cannot be caregivers.” 💠 “Everybody in this room is one diagnosis away from a life changing moment that could jeopardize the very communities and the families who depend on each and every one of us.” 💠 "My mother said-'Do not be afraid to go to whoever holds the power, if you really want to get something big done' and that's why I went to Jill Biden!" 💠 “There is no doubt in my mind that we will make good on this pledge to continue to transform women’s health; no doubt in my mind that we will be table to show women across this nation that they are valued, they are worthy, their lives matter, and their stories are real." 💠 “We women do brave hard things because we recognize that brave hard things are what create a more just, a more tender and more loving world” 💠 “Today I hope we can all tap into what lies within us and light it on fire!” Janine Austin Clayton Vivian OTA WANG Lucy Perez Marsha Henderson Carolee Lee Hadine Joffe, MD Liz Powell Sharon Kedar, CFA Jessica J. Federer Christina K. Isacson Elizabeth Bailey Rachel Butler Erika Seth Davies Elizabeth Comen, MD Stacey E. Rosen, MD, FAHA Kaveeta Vasisht Ketki Karanam Claire Gill Celina Gorre Eliza Lo Chin, MD, Deborah Gomez Autumn Ehnow Sabrina Johnson Audrey Sheppard Sateria Venable Marissa Fayer Sarah Temkin DeChane Dorsey Neil Parikh Millicent Gorham Kathryn Godburn Schubert Irene Aninye Tamsen Fadal Susan Kornstein MD

In the words of our friends at Black Mamas Matter Alliance, Inc. (BMMA) “Every woman has the right to safe and respectful maternal health care. Human rights standards surrounding safe pregnancy, childbirth, and respectful maternal care are rooted in the human rights to life, health, equality, and non-discrimination.” Today, on #HumanRightsDay, we are reflecting on the progress we’ve made–and the work that remains. Globally, maternal health has improved over the past decade, but many women are still being left behind. We are not on track to meet the 2030 UN Sustainable Development Goal to reduce the global maternal mortality ratio to less than 70 deaths per 100,000 live births. This isn’t just a challenge—it’s a call to action. Maternal health is a human right. We cannot stop until it that is fully realized for all women around the world. Learn more about how Every Mother Counts is working to ensure the right to maternal health for women and birthing people around the world and consider supporting our work: www.everymothercounts.org

NUA SURGICAL, a Galway-based medtech firm backed by Enterprise Ireland has raised €6.5M to support its drive for US regulatory approval of its innovative surgical retractor device. A fantastic step forward for Irish innovation in healthcare! Read more: https://lnkd.in/gRPUKksB #MedTech #TechIreland #IrishStartup,

🤔 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝘄𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝘂𝗽 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗳𝗲𝗺𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝘄𝗼𝗺𝗲𝗻'𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸? 𝗛𝗲𝗿𝗲'𝘀 𝘁𝗵𝗲 𝗼𝘂𝗿 𝗿𝘂𝗻-𝗱𝗼𝘄𝗻! 👇 💰 NUA SURGICAL raises €6.5M Series A for C-section retractor innovation. https://lnkd.in/grmY7msS 💰 ModifyHealth secures $13.5M Series C to expand food-as-a-medicine platform. https://lnkd.in/ekvpzzEt 💊 Women's health platform Unfabled launches supplement range at UK's Boots Pharmacy Chain. https://lnkd.in/gGUrgtXC 🔬 Novartis reports extended efficacy of Kisqali in early breast cancer treatment. https://lnkd.in/gfW4jYEX 🔬 Merck announces positive results for KEYTRUDA Ovarian Cancer Treatment Trial. https://lnkd.in/gjzPEWhu 🚀 ConTIPI Medical Ltd launches ProVate device for pelvic organ prolapse in the U.S. https://lnkd.in/gPjBudJn 👩💻 National Academies Report calls for new dedicated The National Institutes of Health and $15.7B for women's health research. https://lnkd.in/gTt9z939 💰 Women's Health Access Matters launches first-of-its-kind women's health investment collaborative. https://lnkd.in/gSt_AQAT 💰 Cure. report reveals key success factors for women's health investment. https://lnkd.in/ghdUbETb ✅ Elaton receives U.S. patent for posture correcting bra design. https://lnkd.in/gwjiA5vP 🚀 Ultrahuman launches free fertility tracking feature for Ring AIR users. https://lnkd.in/gfSE2QfV 🌟 Halle Berry and health experts launch first-ever menopause course on MasterClass. https://lnkd.in/gFM2WCXi #femtech #womenshealthinnovation #research #startup #scaleup #digitalhealth #healthtech #biotech #pharma #venturecapital #vc #partnership #ecosystem #healthtequity #genderhealthgap

Our Chief Operating Officer and Co-Founder Marie-Therese Maher presented a company update at the ATU Innovation Hubs Christmas Client Event today. Marie-Therese spoke of our recent fundraise, our plans for the future and our learnings along the way. She joined Tim Jones of SymPhysis Medical and Damien Rosney of Cocoon Life Science who also provided inspiring presentations of their entrepreneurial journeys. Resilience, dedication, peer support and using the local #medtech ecosystem were all common themes. Enterprise Ireland also played a big part in each company's growth. Well done to George McCourt, Turlough Rafferty and the iHub team for organising a great event!

We are delighted to announce that the company has secured a €6.5 million Series A investment round. The proceeds will be used to drive the manufacturing, testing, regulatory clearance and early commercialization of the company product, the SteriCISION® C-Section Retractor. This innovative device is specifically designed to address the unique challenges of C-section surgery. The Series A financing round was led by the major European healthcare investor EQT Life Sciences, investing through its EQT Health Economics strategy. The round was supported by new investors Texas Medical Center Venture Fund, Kidron Capital, and existing investors including Enterprise Ireland and business veterans from Ireland and the US. We are excited to welcome Anne Portwich and Anula Jayasuriya as incoming board directors as well as Gabrielle Guttman and Prashanthi Ramesh as board observers. There are exciting times ahead for the company which has been given the fuel to make a positive impact on maternal health.

We are delighted to welcome Anne Geary Schmults to the NUA Surgical team in the role of VP of Commercial Strategy. Anne, who is based in Rhode Island, brings three decades of commercial medtech experience to our leadership team and is tasked with implementing the company’s commercial strategy in the US. Anne’s career spans across early stage start-ups and multinationals and she has extensive first-hand knowledge of bringing novel surgical devices to the obstetric market. Commenting on the appointment, CEO Barry Mc Cann stated “We are thrilled to be working with Anne and she joins the company at a very exciting time. It will be a busy few years as we build out our team and establish manufacturing in preparation to enter the US market. Anne’s knowledge of the US healthcare system and particularly in maternal health makes her the perfect fit for NUA!” In recent years, Anne was the Director of Business Development at Alydia Health (acquired by Organon), a company that commercialized the Jada device for the treatment of postpartum hemorrhage. Additionally in obstetrics, Anne served as VP of Commercialisation at Materna Medical, and as a Business Development Consultant at Safe Obstetric Systems (acquired by Cooper Surgical), a company that commercialized the Fetal Pillow. Prior to her focus on women’s health, Anne held senior sales positions with medtech giants including Stryker and Johnson & Johnson and was part of the commercial team of Kyphon (acquired by Medtronic) and Spine Tech (acquired by Sulzer Medica). She currently serves on the Board of Directors of the New England Medical Innovation Center Foundation. Speaking about her new role, Anne Geary Schmults said “I am excited to working with the top notch NUA Surgical team in efforts to reduce obstetric complications.”